$119 Million is the total value of Healthcare Value Capital, LLC's 33 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 53.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TRput | $19,572,000 | +4.7% | 100,000 | 0.0% | 16.42% | +34.2% | |
| TWM | Buy | PROSHARES TRcall | $12,906,000 | +12.5% | 300,000 | +20.0% | 10.82% | +44.3% |
| IWM | Buy | ISHARESput | $11,881,000 | +104.2% | 100,000 | +100.0% | 9.96% | +161.9% |
| AMRI | Buy | ALBANY MOLECULAR RESH INC | $10,024,000 | +20.3% | 498,200 | +11.2% | 8.41% | +54.2% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $7,431,000 | +100.1% | 100,000 | +74.7% | 6.23% | +156.5% |
| ANIP | Buy | ANI PHARMACEUTICALS INC | $6,854,000 | +63.7% | 199,000 | +49.0% | 5.75% | +109.9% |
| TEVA | TEVA PHARMACEUTICAL INDS LTDadr | $6,815,000 | -0.8% | 130,000 | 0.0% | 5.72% | +27.2% | |
| AUXL | Buy | AUXILIUM PHARMACEUTICALS INC | $4,603,000 | -5.6% | 229,481 | +27.9% | 3.86% | +21.0% |
| DGX | QUEST DIAGNOSTICS INC | $4,531,000 | +1.3% | 77,208 | 0.0% | 3.80% | +29.9% | |
| MRK | MERCK & CO INC NEW | $4,454,000 | +1.9% | 77,000 | 0.0% | 3.74% | +30.7% | |
| PFE | Buy | PFIZER INC | $4,452,000 | +38.6% | 150,000 | +50.0% | 3.73% | +77.7% |
| SNY | SANOFIsponsored adr | $3,070,000 | +1.7% | 57,735 | 0.0% | 2.58% | +30.4% | |
| BIS | New | PROSHARES TRcall | $2,848,000 | – | 200,000 | +100.0% | 2.39% | – |
| BIS | Buy | PROSHARES TRultsh nasd biot | $2,848,000 | +27.8% | 200,000 | +60.0% | 2.39% | +63.9% |
| SUPN | SUPERNUS PHARMACEUTICALS INCcall | $2,190,000 | +22.5% | 200,000 | 0.0% | 1.84% | +57.0% | |
| AMRI | ALBANY MOLECULAR RESH INCcall | $2,012,000 | +8.2% | 100,000 | 0.0% | 1.69% | +38.7% | |
| AUXL | Sell | AUXILIUM PHARMACEUTICALS INCcall | $2,006,000 | -75.4% | 100,000 | -66.7% | 1.68% | -68.5% |
| IPXL | New | IMPAX LABORATORIES INC | $1,500,000 | – | 50,000 | +100.0% | 1.26% | – |
| SRNE | Buy | SORRENTO THERAPEUTICS INC | $1,384,000 | +8.0% | 204,968 | +105.0% | 1.16% | +38.4% |
| TWM | PROSHARES TRultsht russ2000 | $1,076,000 | -6.2% | 25,000 | 0.0% | 0.90% | +20.3% | |
| SNSS | Buy | SUNESIS PHARMACEUTICALS INCcall | $978,000 | +195.5% | 150,000 | +200.0% | 0.82% | +277.9% |
| KIN | New | KINDRED BIOSCIENCES INC | $932,000 | – | 50,000 | +100.0% | 0.78% | – |
| SCMP | New | SUCAMPO PHARMACEUTICALS INCcl a | $667,000 | – | 96,630 | +100.0% | 0.56% | – |
| FCSC | Buy | FIBROCELL SCIENCE INC | $629,000 | +11.5% | 157,769 | +46.4% | 0.53% | +43.1% |
| CEMP | New | CEMPRA INC | $537,000 | – | 50,000 | +100.0% | 0.45% | – |
| ZGNX | Buy | ZOGENIX INC | $503,000 | +76.5% | 250,000 | +150.0% | 0.42% | +126.9% |
| GLMD | GALMED PHARMACEUTICALS LTD | $487,000 | -15.2% | 50,000 | 0.0% | 0.41% | +8.5% | |
| ARIA | New | ARIAD PHARMACEUTICALS INC | $478,000 | – | 75,000 | +100.0% | 0.40% | – |
| BOTA | Sell | BIOTA PHARMACEUTIALS INC | $415,000 | -72.3% | 145,507 | -40.7% | 0.35% | -64.5% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $363,000 | -37.6% | 100,000 | -33.3% | 0.30% | -20.2% |
| CLSN | Sell | CELSION CORPORATION | $347,000 | -31.4% | 100,000 | -33.3% | 0.29% | -12.1% |
| STML | STEMLINE THERAPEUTICS INC | $242,000 | -27.8% | 16,464 | 0.0% | 0.20% | -7.3% | |
| CYTK | Sell | CYTOKINETICS INC | $199,000 | -63.0% | 41,666 | -26.5% | 0.17% | -52.6% |
| AMAG | Exit | AMAG PHARMACEUTICALS INCcall | $0 | – | -20,000 | -100.0% | -0.25% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -200,000 | -100.0% | -0.27% | – |
| FURX | Exit | FURIEX PHARMACEUTICALS INC | $0 | – | -5,000 | -100.0% | -0.28% | – |
| ZGNX | Exit | ZOGENIX INCcall | $0 | – | -200,000 | -100.0% | -0.37% | – |
| SNSS | Exit | SUNESIS PHARMACEUTICALS INC | $0 | – | -103,185 | -100.0% | -0.45% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -10,000 | -100.0% | -0.48% | – |
| SUPN | Exit | SUPERNUS PHARMACEUTICALS INC | $0 | – | -106,735 | -100.0% | -0.62% | – |
| PCYC | Exit | PHARMACYCLICS INCput | $0 | – | -10,000 | -100.0% | -0.66% | – |
| QLTI | Exit | QLT INCcall | $0 | – | -200,000 | -100.0% | -0.73% | – |
| ITMN | Exit | INTERMUNE INCcall | $0 | – | -50,000 | -100.0% | -1.10% | – |
| VXX | Exit | BARCLAYS BK PLCcall | $0 | – | -50,000 | -100.0% | -1.38% | – |
| HNT | Exit | HEALTH NET INCcall | $0 | – | -100,000 | -100.0% | -2.22% | – |
| HNT | Exit | HEALTH NET INC | $0 | – | -100,000 | -100.0% | -2.22% | – |
| QLTI | Exit | QLT INC | $0 | – | -626,639 | -100.0% | -2.28% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDcall | $0 | – | -75,000 | -100.0% | -2.59% | – |
| BAX | Exit | BAXTER INTL INCcall | $0 | – | -100,000 | -100.0% | -4.81% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INCput | $0 | – | -125,000 | -100.0% | -5.19% | – |
| MDY | Exit | SPDR S&P MIDCAP 400 ETF TRput | $0 | – | -50,000 | -100.0% | -8.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-08-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.